SonoThera
PrivateLast Round
Series B
Jun 10, 2026
Total Funding Raised
$185.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SonoThera is a biotechnology company that develops ultrasound-guided nonviral gene therapy platforms to treat the root causes of human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SonoThera Comparables
Compare SonoThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BreezeBio | 81% | |
| Danaher | 74% | |
| Aera Therapeutics | 74% |
SonoThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 10, 2026 | ||||
| Series A | Dec 5, 2022 |
Key People
Founding team and executive leadership
SonoThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifespan Financial Planning | Series A |
| UCB Ventures | Series B |
| SymBiosis Capital Management | Series B |
| RA Capital Management | Series B |
| Vertex Ventures HC | Series B, Series A |
| CureDuchenne Ventures | Series B |
| ARCH Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$125M round closed.
- Mar 5, 2026
Presented preclinical data on RIPPLE(TM) platform for Duchenne muscular dystrophy at MDA 2026.
Recent news
Latest coverage and updates
- hiresSep 14, 2026
SonoThera, Inc. hired Adam Shaywitz as Chief Medical Officer on Sep 14th '26.
SonoThera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SonoThera's valuation, stock price, and market status.
Is SonoThera a public or private company?
SonoThera is a private company.
What is the current stock price of SonoThera?
SonoThera is a private company with no public stock price. No recent secondary market data is available.
How much is SonoThera worth (valuation)?
Valuation information for SonoThera is not publicly available.
Can I buy SonoThera stock?
SonoThera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SonoThera's last funding round?
SonoThera's most recent funding round was Series B on June 10, 2026.
Who are the main investors in SonoThera?
Key investors in SonoThera include Vida Ventures, ARCH Venture Partners.
Will SonoThera IPO soon?
No public IPO plans have been announced for SonoThera.
How can I track SonoThera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SonoThera's secondary market activity and sign up for updates.